XOMA Corporation
(XOMA)
undefined
undefined%
At close: undefined
27.15
-0.01%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific.
The company engages in helping biotech companies for enhancing human health.
It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners.
It has a portfolio with approximately 70 assets.
XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Corporation
| Country | United States |
| IPO Date | Jun 6, 1986 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Owen P. Hughes Jr. |
Contact Details
Address: 2200 Powell Street EmeryVille, California United States | |
| Website | https://www.xoma.com |
Stock Details
| Ticker Symbol | XOMA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000791908 |
| CUSIP Number | 98419J206 |
| ISIN Number | US98419J2069 |
| Employer ID | 52-2154066 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Owen P. Hughes Jr. | Chief Executive Officer & Director |
| Thomas M. Burns | Senior Vice President of Finance & Chief Financial Officer |
| Brad Sitko | Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 02, 2024 | 8-K | Current Report |
| Nov 13, 2024 | 4 | Filing |
| Nov 13, 2024 | 4 | Filing |
| Nov 07, 2024 | 8-K | Current Report |
| Nov 07, 2024 | 10-Q | Quarterly Report |
| Oct 22, 2024 | 8-K | Current Report |
| Sep 23, 2024 | 8-K | Current Report |
| Aug 13, 2024 | 8-K | Current Report |
| Aug 13, 2024 | 10-Q | Quarterly Report |
| Jul 09, 2024 | 8-K | Current Report |